SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030039
Filing Date
2019-08-07
Accepted
2019-08-07 16:03:13
Documents
51
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cbay-10q_20190630.htm   iXBRL 10-Q 2446869
2 EX-10.1 cbay-ex101_57.htm EX-10.1 128241
3 EX-31.1 cbay-ex311_8.htm EX-31.1 15433
4 EX-31.2 cbay-ex312_6.htm EX-31.2 15336
5 EX-32.1 cbay-ex321_7.htm EX-32.1 8007
6 GRAPHIC gsuw3ujmxxzi000001.jpg GRAPHIC 4951
  Complete submission text file 0001564590-19-030039.txt   8226234

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA cbay-20190630.xsd EX-101.SCH 33540
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20190630_cal.xml EX-101.CAL 45832
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20190630_def.xml EX-101.DEF 80722
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20190630_lab.xml EX-101.LAB 282792
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20190630_pre.xml EX-101.PRE 202195
12 EXTRACTED XBRL INSTANCE DOCUMENT cbay-10q_20190630_htm.xml XML 1914884
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36500 | Film No.: 191005413
SIC: 2834 Pharmaceutical Preparations